基于包被溶瘤病毒的“双重打击”策略在胃肠道肿瘤中触发 CD19 CAR-T 治疗
Coated oncolytic viruses based "double strike" strategy triggering CD19 CAR-T therapy in gastrointestinal tumors.
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Coated oncolytic viruses based "double strike" strategy triggering CD19 CAR-T therapy in gastrointestinal tumors.
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer.
Challenges and perspectives of CAR-T cell therapy in solid tumours: insights from gastric cancer.
Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance.
Rapid Isolation of Gastric Adenocarcinoma Cancer Stem Cells as a Target for Autologous Dendritic Cell-Based Immunotherapy.
我们提出,球体形成实验和致瘤性实验是两种方法,可快速分离具有特定干性特征的癌细胞,以便利用自体树突状细胞疗法靶向 CSCs,尤其是在晚期疾病患者中。
MEMBER ACCOUNT
登录成功会直接打开下一页。